KLP Kapitalforvaltning’s Terns Pharmaceuticals TERN Stock Holding History

KLP Kapitalforvaltning’s Portfolio TERN Stock Details TERN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-12,500	Closed	-$659K	–	2196
2026 Q1	$659K	Buy	+12,500	New	+$513K	﹤0.01%	1269

Other funds holding TERN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

KLP Kapitalforvaltning's TERN Position: Q2 2026 in Review

KLP Kapitalforvaltning sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 12,500 shares — an estimated $659K sold.

KLP Kapitalforvaltning first reported a position in TERN in Q1 2026 and held it in 1 quarter. The position peaked at $659K in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

KLP Kapitalforvaltning reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
KLP Kapitalforvaltning sold 12,500 Terns Pharmaceuticals shares in Q2 2026, an estimated $659K.
KLP Kapitalforvaltning first reported a position in Terns Pharmaceuticals in Q1 2026 and held it in 1 quarter.
KLP Kapitalforvaltning's Terns Pharmaceuticals position peaked at $659K in Q1 2026.
1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2026, filed 12 Aug 2026.